Mefenamic Acid Chemidex Pharma (Mefenamic Acid)

Mefenamic acid inhibits both COX‑1 and COX‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, the drug diminishes inflammation, pain perception, and fever responses at the site of tissue injury.

The specific dose of Mefenamic Acid Chemidex Pharma is determined by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. Only a qualified health professional should set the dosage regimen.

Safety data for mefenamic acid in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mefenamic acid belongs to the anthranilic acid class of NSAIDs and offers analgesic and anti‑inflammatory effects similar to ibuprofen or naproxen. Its potency for dysmenorrhea is often highlighted, but like other NSAIDs, it shares comparable gastrointestinal and renal safety considerations.

Mefenamic Acid Chemidex Pharma should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight to maintain stability.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with meals may reduce stomach irritation. Patients should follow the prescribing clinician’s instructions for timing and frequency.

Serious adverse events include gastrointestinal bleeding or ulceration, severe renal impairment, hepatic injury, life‑threatening skin reactions such as Stevens‑Johnson syndrome, and anaphylaxis. Prompt medical attention is required if any of these symptoms develop.

Mefenamic acid is contraindicated in individuals with known hypersensitivity to the drug or other NSAIDs, active gastrointestinal ulcers, severe renal or hepatic disease, and in patients who have experienced previous serious skin reactions to NSAIDs. Clinicians should evaluate each patient’s medical history before prescribing.